The Allergic Rhinitis Knowledge Centre hosts a number of resources which you may find useful for furthering your understanding of the condition and to assist with patient interaction. Click on these links to jump to useful links, videos, case studies and downloads.
Listed below are various short videos which cover:
Help your patients track their allergy symptoms and treatment with Allergy Diary by MACVIA-ARIA
This video explains how to use the Allergy Diary by MACVIA-ARIA application, and how it allows patients to record daily allergy symptoms and track symptom control.
In this short video from SERIN Congress 2017, the study investigates the effectiveness of MP-AzeFlu in patients with persistent allergic rhinitis.
Three posters are explored in this video, detailing the burden of allergic rhinitis and its impact on asthma in Australia.
View up-to-date guidelines, reports and algorithms to assist you with the accurate diagnosis and treatment of your patients.
This document was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology (JCAAI) and features key updates to specifications and guidelines for the treatment of patients.
The 2008 revision of the ARIA Report, published as a Supplement in the European Journal of Allergy and Clinical Immunology, reviews the latest scientific evidence on the definition and classification of rhinitis, risk factors, mechanisms, and diagnosis and treatment, with extensive citations from the scientific literature.
Allergic rhinitis affects more than 20% of the population in the United Kingdom and Western Europe and represents a major cause of morbidity that includes interference with usual daily activities and impairment of sleep quality. This guidance prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) is for the management of AR in patients that have failed to achieve adequate relief of symptoms despite treatment with intranasal corticosteroids and/or antihistamines.
The selection of pharmacotherapy for patients with allergic rhinitis is dependent on several factors, including age, symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment amendment may be required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control and are discussed by this paper.